Ticker Details
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
IPO Date:	October 5, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$7.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.00 | 3.04%
Avg Daily Range (30 D):	$2.81 | 2.58%
Avg Daily Range (90 D):	$2.21 | 2.24%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.52M
Avg Daily Volume (90 D):	.6M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	3,382
Avg Institutional Trade:	$3.06M
Avg Institutional Trade (30 D):	$5.31M
Avg Institutional Trade (90 D):	$5.01M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.58M
Avg Closing Trade (30 D):	$9.37M
Avg Closing Trade (90 D):	$10.9M
Avg Closing Volume:	102.51K

News

Aug 4, 2026 @ 10:55 AM Rhythm Pharmaceuticals Announces Preliminary Data ... Source: Na

Jul 17, 2026 @ 1:16 AM Kuehn Law Encourages Investors of Rhythm Pharmaceu... Source: Kuehn Law, Pllc

Jun 15, 2026 @ 4:51 PM Why Is Rhythm Pharma Stock Jumping Today? Source: Vandana Singh

May 29, 2026 @ 12:00 PM Rhythm Pharmaceuticals Announces Seven Abstracts A... Source: Na

May 26, 2026 @ 12:00 PM Rhythm Pharmaceuticals Announces Participation in ... Source: Rhythm Pharmaceuticals, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.11	$-.73	$-.83
Diluted EPS	$-3.11	$-.73	$-.83
Revenue	$239.92M	$71.26M	$60.11M
Gross Profit	$213.53M	$62.32M	$52.96M
Net Income / Loss	$-205.35M	$-49.3M	$-55.64M
Operating Income / Loss	$-200.63M	$-48.55M	$-52.36M
Cost of Revenue	$26.39M	$8.93M	$7.16M
Net Cash Flow	$-70.5M	$3.7M	$7.47M
PE Ratio